Rotavirus injury compensation
Executive Summary
Public hearing is planned to discuss HHS' proposal to add "vaccines containing live, oral rhesus-based rotavirus" to the National Vaccine Injury Compensation Program's vaccine injury table as a distinct category, with intussusception listed as a covered injury. The hearing will occur in conjunction with the Advisory Commission on Childhood Vaccines' next meeting, scheduled for early December in FDA's Parklawn Building in Rockville, Md. The notice of proposed rulemaking, published in the Federal Register July 13, would cover intussusception cases that "have an onset interval of 30 days"
|
Public hearing is planned to discuss HHS' proposal to add "vaccines containing live, oral rhesus-based rotavirus" to the National Vaccine Injury Compensation Program's vaccine injury table as a distinct category, with intussusception listed as a covered injury. The hearing will occur in conjunction with the Advisory Commission on Childhood Vaccines' next meeting, scheduled for early December in FDA's Parklawn Building in Rockville, Md. The notice of proposed rulemaking, published in the Federal Register July 13, would cover intussusception cases that "have an onset interval of 30 days". |